Skip to main content

Decision Making

Back to Non-Medication Clinical Trials 

Many researchers think that brain circuits involving the neurotransmitter dopamine are responsible for helping us use rewards to guide behavior. Since all antipsychotic drugs act on dopamine receptors, there is reason to suspect that either the illness itself or treatments may impact this system. One goal of this current study is to explore how people use rewards to make decisions about everyday things.  A second goal of the study is to explore how people with schizophrenia process rewards and whether the types of medicines they take affect decision making ability.

Give to Center


Join a Study


Videos

Former MPRC Director, Dr. Robert W. Buchanan, provides an overview of the center.


Robert Schwarcz, Ph.D. wins the 2022 Lieber Prize for Outstanding Achievement in Schizophrenia Research from the Brain & Behavior Research Foundation



News and Events